Skip to main content
Clinical Trials/NCT00851071
NCT00851071
Completed
N/A

Bakken Heart Brain Institute's "An Observational and Interventional Study of Anxiety Symptoms in the Implantable Cardioverter Defibrillator (ICD) Patient."

The Cleveland Clinic1 site in 1 country28 target enrollmentFebruary 2009
ConditionsAnxiety

Overview

Phase
N/A
Intervention
Not specified
Conditions
Anxiety
Sponsor
The Cleveland Clinic
Enrollment
28
Locations
1
Primary Endpoint
Patients in the CBT intervention arm will have a higher reduction in anxiety and experience better quality of life compared to usual care at 3 months.
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This study will compare the effectiveness that Cognitive Behavioral Therapy has on decreasing the amount of anxiety, as well as the number of inappropriate firings that a patient with an ICD may experience.

Detailed Description

This study is an interventional study of patients with ICDs followed in the Cleveland Clinic Device Clinic. Patients with ICDs experience some level of anxiety which can impact the number of shocks that they receive from their Device. 100 of these patients will be randomized into one of 2 groups; those receiving three sessions of Cognitive Behavioral Therapy (CBT) and those receiving usual care. We hypothesize that if these ICD patients receive short term (CBT) they will experience less anxiety and have a lower rate of device firings than the patients that did not receive CBT. Furthermore, we will study mechanistic pathways involved in the reduction of anxiety in ICD patients. We will extract initial heart rate variability (HRV) data from device interrogation. We hypothesize that the CBT intervention arm will have a higher normalization of HRV. Patients will repeat questionnaires at 3, 6 and 12 months.

Registry
clinicaltrials.gov
Start Date
February 2009
End Date
December 20, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mina Chung

MD

The Cleveland Clinic

Eligibility Criteria

Inclusion Criteria

  • Currently has an Implantable Cardioverter Defibrillator (ICD)
  • Experiences moderate to high anxiety as demonstrated by the the scores on the questionnaires that will be administered

Exclusion Criteria

  • Unwilling to comply with follow-up requirements at 3, 6 and 12 months.

Outcomes

Primary Outcomes

Patients in the CBT intervention arm will have a higher reduction in anxiety and experience better quality of life compared to usual care at 3 months.

Time Frame: Patients in the CBT arm will have (3) 45min. sessions scheduled over a 3 month period.

Secondary Outcomes

  • Patients in the CBT intervention arm will have a lower rate of firings (shocks).(Patients in both arms will have their ICD's interrogated at 3, 6 and 9 months.)

Study Sites (1)

Loading locations...

Similar Trials